Log in
Enquire now
‌

US Patent 9212230 Bispecific antibodies and methods for production thereof

Patent 9212230 was granted and assigned to Genmab A/S on December, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
‌
Genmab A/S
Date Filed
March 28, 2008
Date of Patent
December 15, 2015
Patent Application Number
12593759
Patent Citations Received
‌
US Patent 11858995 Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
0
‌
US Patent 11987644 Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
0
‌
US Patent 11970544 Antibodies
0
‌
US Patent 11660340 Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function
0
‌
US Patent 11866514 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9212230
Patent Primary Examiner
‌
Brad Duffy

Find more entities like US Patent 9212230 Bispecific antibodies and methods for production thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.